Related Experiment Video
Updated: May 11, 2026
11:36
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
Galectins as cancer biomarkers
Vitaly Balan1, Pratima Nangia-Makker, Avraham Raz
1Karmanos Cancer Institute, Wayne State University, 110 E. Warren Avenue, Detroit, MI 48201, USA.
Cancers
|May 10, 2013
Summary
Galectins, proteins binding beta-galactosides, are found across species and cellular locations. Their expression correlates with tumor progression, highlighting their potential as cancer diagnostic markers.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Galectins are a conserved protein family binding beta-galactosides via their carbohydrate recognition domain (CRD).
- Galectins exhibit diverse subcellular localization (cytoplasm, nucleus) and extracellular functions.
- Evolutionarily, galectin-like proteins are found in primitive organisms like sponges.
Purpose of the Study:
- To review the expression and function of galectins in various cancers.
- To explore the clinical applications of galectins as tumor markers.
Main Methods:
- Literature review of experimental and clinical data.
- Analysis of galectin expression patterns in different cancer types.
Main Results:
- Galectin expression is linked to tumor progression and metastasis.
- Galectins demonstrate potential as reliable biomarkers for cancer diagnosis.
Conclusions:
- Galectins play significant roles in cancer development.
- Galectins offer promising avenues for cancer diagnostics and therapeutic strategies.
Related Concept Videos
01:25Selectins
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...